Clinical and Molecular Epidemiology of Pretransplant Vancomycin-Resistant Enterococci (VRE) Colonization Among Patients Who Undergo Liver Transplantation.

2014 ◽  
Vol 98 ◽  
pp. 769
Author(s):  
D. Banach ◽  
D. Peaper ◽  
S. Emre ◽  
B. Fortune ◽  
L. Dembry
Keyword(s):  
Liver Transplantation ◽  
Molecular Epidemiology ◽  
Undergo Liver Transplantation ◽  
Vancomycin Resistant Enterococci ◽  
Vancomycin Resistant

Molecular epidemiology of vancomycin-resistant enterococci in Singapore

Pathology ◽  
2009 ◽  
pp. 1-5
Author(s):  
Tse Koh ◽  
Beng Low ◽  
Nicholas Leo ◽  
Li-Yang Hsu ◽  
Raymond Lin ◽  
...  
Keyword(s):  
Molecular Epidemiology ◽  
Vancomycin Resistant Enterococci ◽  
Vancomycin Resistant

Molecular epidemiology of vancomycin–resistant enterococci in Singapore

Pathology ◽  
2009 ◽  
Vol 41 (7) ◽  
pp. 676-680 ◽  
Author(s):  
Tse H. Koh ◽  
Beng S. Low ◽  
Nicholas Leo ◽  
Li-Yang Hsu ◽  
Raymond T.P. Lin ◽  
...  
Keyword(s):  
Molecular Epidemiology ◽  
Vancomycin Resistant Enterococci ◽  
Vancomycin Resistant

A change in the molecular epidemiology of vancomycin resistant enterococci in Western Australia

Pathology ◽  
2014 ◽  
Vol 46 (1) ◽  
pp. 73-75 ◽  
Author(s):  
Geoffrey W. Coombs ◽  
Denise Daley ◽  
Julie C. Pearson ◽  
Paul R. Ingram
Keyword(s):  
Molecular Epidemiology ◽  
Western Australia ◽  
Vancomycin Resistant Enterococci ◽  
Vancomycin Resistant

scholarly journals Importance of daptomycin dosage on the clinical outcomes in early post-liver transplant recipients with vancomycin-resistant enterococci infection

2021 ◽  
Author(s):  
Ing-Kit Lee ◽  
Yi-Ping Sng ◽  
Wei-Feng Li ◽  
Chao-Long Chen ◽  
Chih-Chi Wang ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Liver Transplant ◽  
Transplant Recipients ◽  
Donor Liver ◽  
Level Of Evidence ◽  
Donor Liver Transplantation ◽  
Vancomycin Resistant Enterococci ◽  
Vancomycin Resistant ◽  
Liver Transplant Recipients ◽  
The Impact

Abstract Background: The prevalence of vancomycin-resistant enterococci (VRE) is increasing among liver transplant recipients. This study aimed to explore the clinical features of liver transplant recipients with VRE infection/colonization and to determine the impact of daptomycin dosage on the outcomes. Methods: We retrospectively enrolled pre-transplant and post-transplant patients with VRE colonization/infection from 2016 to 2019. Results: Altogether, 428 patients underwent liver transplantation. Among these, 22 (5.1%) patients developed VRE colonization/infection. All VRE isolates were Enterococcus faecium. Two (9%) patients acquired VRE in the pre-transplant period, 16 (3 colonizations and 13 infections) (72.7%) in the early post-liver transplant period (≤60-day after transplantation), and 4 (2 colonization and 2 infections) (18.1%) in the late post-liver transplant period (>6-month after transplantation). Among 13 patients with early post-liver transplant VRE infection, 12 (92.3%) underwent living-donor liver transplantation and 1 underwent deceased donor liver transplantation. Among these 13 patients, the median time from transplant to emergence of VRE infection was 12 days. The median interval from VRE infection to death was 27 days and the 30-day mortality was 67%. Of these 13 patients, eleven patients (8 survived; 3 died) received daptomycin therapy for VRE. Among them, 4 (36.3%) received daptomycin doses <8 mg/kg. Non-survivors (n=3) received significantly lower daptomycin dose than survivors (n=8) (P=0.040). Daptomycin doses <8mg/kg were more frequently associated with non-survivors (n=3) than with survivors (n=8) (P=0.024). Conclusions: In summary, the suboptimal dosage of daptomycin may have contributed to a higher rate of in-hospital mortality. Doses ≥8 mg/kg may be needed to adequately treat VRE infection in early post-liver transplant recipients.Level of evidence: Level III

scholarly journals Molecular Epidemiology of Hospital-Acquired Vancomycin-Resistant Enterococci

2006 ◽  
Vol 44 (11) ◽  
pp. 4009-4013 ◽  
Author(s):  
M. Abele-Horn ◽  
U. Vogel ◽  
I. Klare ◽  
C. Konstabel ◽  
R. Trabold ◽  
...  
Keyword(s):  
Molecular Epidemiology ◽  
Vancomycin Resistant Enterococci ◽  
Vancomycin Resistant ◽  
Hospital Acquired

Epidemiology of Infection and Colonization With Vancomycin-Resistant Enterococci and Frequency of Cocolonization With Methicillin-Resistant Staphylococcus aureus in Children

2007 ◽  
Vol 28 (7) ◽  
pp. 880-882 ◽  
Author(s):  
Lacey Benson ◽  
Bruce Sprague ◽  
Joseph Campos ◽  
Nalini Singh
Keyword(s):  
Staphylococcus Aureus ◽  
Molecular Epidemiology ◽  
Active Surveillance ◽  
Clinical Evidence ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Methicillin Resistant ◽  
Vancomycin Resistant Enterococci ◽  
Vancomycin Resistant

We report the descriptive and molecular epidemiology of vancomycin-resistant enterococci (VRE) infection and colonization and cocolonization with methicillin-resistant Staphylococcus aureus (MRSA) in children. Interunit and intraunit spread of VRE was detected, and 8 cases of VRE-MRSA cocolonization were identified. Seven of these cases were identified only via active surveillance, because clinical evidence of VRE colonization was absent.

Molecular epidemiology of vancomycin-resistant enterococci from 6 hospitals in New York State☆☆☆★

1999 ◽  
Vol 27 (5) ◽  
pp. 411-417 ◽  
Author(s):  
Lawrence H. Bopp ◽  
Dianna J. Schoonmaker ◽  
Aldona L. Baltch ◽  
Raymond P. Smith ◽  
William J. Ritz
Keyword(s):  
New York ◽  
Molecular Epidemiology ◽  
New York State ◽  
York State ◽  
Vancomycin Resistant Enterococci ◽  
Vancomycin Resistant
Sign in / Sign up

Export Citation Format

Share Document